Rifampin inhibits the replication of a few deoxyribonucleic acid (DNA) viruses such as vaccinia, cowpox, and possibly adenovirus, whereas several ribonucleic acid (RNA) viruses are insensitive to this drug (6) . Recently, Diggelmann and Weissmann (3) reported that morphological conversion by Rous sarcoma virus (RSV), an oncogenic RNA virus of the avian leukosis groups, is inhibited by rifampin. With this group of viruses, however, the viral information within the cells is thought to be in the form of a DNA provirus (8, 9) . We recently investigated the role of the provirus in morphological conversion and found that intracellular inactivation of proviral DNA by treatment with 5-bromodeoxyuridine (BUdR) and visible light results in suppression of focus formation by RSV (1) . Since it is known that rifampin in bacteria blocks DNA transcription by binding to the DNA-dependent RNA polymerase complex (4), we thought it of interest to investigate whether rifampin inhibits focus formation of RSV by affecting the proviral DNA.
The results of our experiments suggest that rifampin at the dose used here does not affect the virion-associated enzymes involved in the synthesis of proviral DNA recently described by Temin and Mizutani (11) nor does it affect transcription or translation of the provirus after fixation of the transformed state as defined by Temin (9) . Rather, the drug inhibits an early event which I Part of this work has been carried out by N. J. Richert, National Institutes of Health predoctoral trainee, in partial fulfillment of the requirement for a degree of Doctor of Philosophy and was presented at the 69th Annual Meeting of the American Society for Microbiology, Boston, Mass., 26 April-i May, 1970. takes place in infected cells, presumably after the synthesis of the provirus, and which affects both fixation of the transformed state and activation of virus production.
MATERIALS AND METHODS
The Bryan high-titer strain of Rous sarcoma virus [B-RSV-(RAV-1)] and chick embryofibroblasts (CEF) cultures were used as previously described (1) . Focusforming unit (FFU) assays and infectious center assays were carried out by established procedures (12) . All experiments reported here were carried out with secondary cultures of CEF brought to a stationary phase by the use of Eagle's minimal essential medium (MEM) without serum as already described (1) . Rifampin was kindly supplied through the courtesy of F. Nicolis and G. C. Lancini, Lepetit SPA (Milano, Italy). To study the effect of rifampin on focus formation, second-passage stationary phase cultures of CEF were infected with approximately 100 FFU of virus and fed after adsorption with growth medium containing antiserum against B-RSV-(RAV-1) to prevent secondary infections. Different sets of plates were exposed to rifampin during different 24-hr periods starting from day 0 (time of infection) and for several days thereafter. Both rifampin-treated cultures and controls without rifampin were overlaid with agar medium containing no rifampin at the end of the last treatment period.
RESULTS

Preliminary
The results presented in Table 1 indicate that rifampin does not significantly affect the early phase of infection when the synthesis of proviral DNA is known to occur (10) . Rather, rifampin seems to inhibit some early event after the formation of the provirus, since the inhibition of focus formation is maximal with exposure to rifampin between 24 and 48 hr after infection (experiments 1 and 2). Moreover, exposure to the drug from day 0 to day 2 does not increase the level of inhibition of focus formation over exposure between day 1 to day 2 (experiment 3).
The degree of inhibition obtained in different experiments varied considerably with different embryos. No complete or near complete suppression of focus formation was ever obtained in these conditions, the maximum inhibition observed being usually between 50 and 75%. With some embryos, no significant inhibition could be detected. The reasons for such failure to suppress focus formation are not understood at present.
To determine whether the steps involved in the fixation of the transformed state, namely cell DNA synthesis and cell division (9), were affected by rifampin, experiments were carried out in which stationary cultures were infected and maintained in MEM medium without serum for 24 hr after infection. In these conditions, synthesis of the provirus is known to occur (1, 10) . The cultures were then exposed to rifampin between day 1 and day 2 postinfection in either growth medium or MEM without serum in the presence of antiserum against RSV. At the end of this 24-hr period, the cultures were overlaid with F12 agar medium, and the foci were counted 8 days later.
The results of these experiments (Table 2) show that inhibition by rifampin occurs also in cultures maintained in stationary phase during the treatment. This suggests that the inhibition does not depend on cellular DNA synthesis and occurs before the fixation step. However, no data are available on the residual effects of rifampin after removal of the drug.
To investigate whether the effect of rifampin on focus formation is paralleled by an inhibition of virus production, the following experiments were performed.
The effect of rifampin on focus formation was determined as before. Similar sets of plates were infected at a multiplicity of about 0.1 to 0.2 a Stationary cultures of chick embryo fibroblasts were infected with 100 focus-forming units/plate of Bryan high-titer strain of Rous sarcoma (RAV-1) virus and fed with F12 medium with 5% calf serum. At the time indicated, rifampin at a final concentration of 50 ug/ml (expt 1) and 100 jAg/mi (expt 2 and 3) was added to the cultures. Plates were overlaid after the rifampin treatment with F12 agar medium without rifampin. sensitive cells in the presence of RSV antiserum, and overlaid the next day to assay the number of infectious centers.
The results (Table 3) indicate that the suppression of focus formation is paralleled by an inhibition of virus production. Furthermore, the number of virus-producing cells as obtained by the infectious center assay is reduced to the same extent as virus production. This indicates that inhibition of virus production is not due to a decreased production of virus per infected cell but to a reduction in the number of virus-producing cells. In other experiments, exposure to rifampin for 24 hr at day 2 and day 4 after infection did not affect virus production (Table 4) . DISCUSSION The findings of Diggelmann and Weismann (3) were confirmed by the present study only in part. The amount of inhibition of focus formation obtained in our system did not approach the values observed by these authors. On the other hand, it was found that the suppression of focus formation was paralleled by inhibition of virus production. The results of our study also indicate that maximum effect on focus formation and virus production by rifampin occurs during a critical period of time between day 1 and day 2 after infection. It was found previously that proviral synthesis in CEF occurs to a large extent during the first 24 hr after infection, as shown by the fact that inhibitors of DNA synthesis are effective in suppressing focus formation only if they are present during the 24-hr period immediately after infection (10) . These findings were also confirmed by experiments of inactivation of focus formation by treatment with BUdR and light (1, 2) . Since there is little or no focus suppression if cells are treated with rifampin during the first 24 hr, it seems that rifampin does not inhibit transcription of viral RNA by the recently described enzymes associated with the virion (11) . This is in agreement with the recent finding by Green and co-workers (5) obtained with several RNA tumor viruses.
Rifampin, however, seems to act before the activation of the provirus. It is known that this process requires the synthesis of cellular DNA (9) . In our experience, maintenance of cultures in MEM without serum effectively keeps the cells in stationary phase (1) . Yet The mechanism by which rifampin inhibits morphological conversion and virus production is not clear. Two possibilities can be considered. The first is that some provirus-specific function is affected by the drug. At present, no proviral functions are known to occur before fixation and activation of viral production take place, but such a possibility should be kept in mind in light of the required functioning of the viral genome before integration occurs in X phage (7) .
Alternatively, a cell-mediated effect of rifampin which would delay fixation could be considered.
In either case, a nonintegrated provirus would be expected to decay, according to data by Boettiger (2) 
